Autoinjectors to 2018 Devices, Therapeutics, Markets, Strategies and Prospect

Greystone Associates, March 2013

While autoinjectors are sometimes designed to work with a particular injectable product as a form of pharmaceutical branding, the typical autoinjector is designed to fit one or more standard sizes of prefilled disposable syringes. Until recently, autoinjectors were designed to be reused. The reason was that the injectors were too expensive to be successfully marketed as a throw-away device. Recent improvements in materials technology and device design have led to the creation of a class of autoinjectors that can be made economically in high production quantities, opening the door for the disposable autoinjector, and providing expanded opportunities for both patient and drug marketer.

Highlights

- Analyzes therapeutic demand drivers and evaluates commercial prefilled syringe products in eleven major therapeutic segments

- Analyzes design factors, material selection issues, technologies and market development issues

- Profiles injectable drug and device participants, their product development activities, business strategies, and corporate alliances and affiliations

- Charts market data and forecasts to 2018

Executive Summary

Injectable Drug Delivery Market Dynamics

The Economics of Injectable Drugs
What’s Driving the Growth in Autoinjectors?
Prefilled Syringes Proliferating
The Trend toward Self-Administration
Shifting Demographics
Innovation in Disposable Device Designs
Therapeutic Demand Drivers
Competitive Landscape
Risk Factors

Autoinjectors – Commercial Devices

Manual injection Autoinjectors
Automated Injection Autoinjectors
Reusable Autoinjectors
Disposable Autoinjectors
Bundled (Pre-assembled) Autoinjectors
Product Specific Autoinjectors

Autoinjector Device Design Factors

Material Selection Issues
Part Counts and Device Cost
Safety Features
Needle Shielding
Needle Insertion Depth
Failsafe Activation
Dose Inspection/Injection Confirmation
Lyophilized Drugs/Reconstitution
Human Engineering/Ergonomics

Autoinjector Drug Delivery – Key Therapeutic Sector Analysis

Anticoagulants
Autoimmune Diseases
Rheumatoid Arthritis
Multiple Sclerosis
Psoriasis
Emergency Medicine
Hepatitis
Hematopoietics
Hormones
Reproductive Health

Market Factors

Regulatory Issues
Device Branding
Patient Compliance
Healthcare Economics
Ease of Use

Autoinjector Devices - Company Profiles

Product Samples

A sample for this product is available. Please Login/Register to download this sample.

Customers who bought this item also bought

• Injectable Drug Delivery to 2018 Drugs, Devices, Targets, Therapeutics and Forecasts
• Advanced Devices for Injectable Drugs. Products, Players and Prospects
• Pen Injectors Devices, Drugs, Combination Products
• Prefilled Syringes to 2018 Devices, Drugs, Markets, Players and Prospects
• Product Strategies for Non-Oral Hematology Drugs
• Drug Reconstitution at the Point-of-Care: Therapeutic Markets, Technologies, Strategies, and Prospects
• Innovations in Drug Delivery - Broad-based Proprietary Technology Platforms to Address Delivery Efficiency and Improve Patient Compliance
• Point-of-Delivery Drug Reconstitution Systems
• Point-of-Delivery Drug. Reconstitution Systems Markets, Strategies and Prospects
• Drug Self-Administration to 2018 Drug Products, Indications, Markets and Forecasts